|
|
|
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
Detection of Rifampin Resistance Mutation of Mycobacterium leprae from Korean Leprosy Patients |
|
|
|
|
ÀúÀÚ |
Soon Ok Kim, You Kyung Yang, Gue Tae Chae#, Hae Young Choi##, and Joo Won Suh |
¼Ò¼Ó |
Dept. of Biological Science, Myong-Ji University, Institute of Chronic Diseases, Catholic University Medical College, Seoul, Ewa-Hwa Women's University, Mok-dong Hospital, Seoul, Korea## |
|
|
³âµµ |
1997 |
±Ç |
30 |
|
|
È£ |
2 |
¹øÈ£ |
|
|
|
½ÃÀÛÆäÀÌÁö |
57 |
³¡ÆäÀÌÁö |
67 |
|
|
÷ºÎ |
|
|
|
¿ä¾à |
Rifampin is a important component of multidrug therapy in leprosy and tuberculosis. It inhibits initiation and elongation of RNA transcription by binding ¥â-subunit of RNA polymerase which is encoded from ¥ãpoB. However, with rifampin resistant Mycobacterium leprae have been reported in relapsing patients, leprosy control program is more difficult than before. We developed the efficient method for detection of rifampin resistance mutation, and isolated 2 variant strains of M. leprae from Korean leprosy patients by PCR-SSCP of the ¥ãpoB gene. With nucleotide sequencing, it is revealed that 6 missense mutations which altered at Leu-449, Gly-461, Ser-464, Arg-465, Arg-467 and Ala-468, and 2 silent mutations at Arg-454 and Gly-461. Two variant strains have same mutation at some parts that is Ser-464, Arg-465, Arg-467 and Ala-468. These common mutated areas might be very important target site of rifampin activity. |
|
|
³»¿ë |
|
| |
¡¡ |
|
|
|
|
|
|
|
|